Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Glycolic Acid vs Thiamidol: Thiamidol has the stronger overall evidence (6.5 vs 6/10); they're alternatives for even skin tone — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Thiamidol wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (2)
Outcomes where both Glycolic Acid and Thiamidol have evidence — compare verdict strength side-by-side.
Topical cosmetic only. Leave-on glycolic acid is used at roughly 5-15% in lotions/serums (often at low pH), applied to clean skin a few nights per week and building as tolerated; professional peels (20-70%) are applied in-office at intervals. There is no oral, injectable, or systemic dose — it is not ingested. Pair with daily sunscreen. This library does not provide an ingestion protocol.
Evening
Leave-on lotion or serum (≈5-15% glycolic acid)
A source-matched dose range is not available for this product and use.
Morning, Evening
Thiamidol 0.2% serum
Throughout
8-12 weeks
8-16 weeks
First weeks
immediate
12 weeks
2-3 weeks
3 weeks
A double-blind randomized clinical trial on the effectiveness of a daily glycolic acid 5% formulation in the treatment of photoaging.
Dermatol Surg (1998) · RCT · n=75
75 volunteers applied 5% unneutralized glycolic acid cream or placebo to face and neck daily for 3 months (double-blind, randomized, placebo-controlled)
Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study.
Dermatol Surg (1996) · RCT · n=41
41 volunteers received a 50% glycolic acid peel vs vehicle weekly for 4 weeks (in-office peel strength)
Mode of action of glycolic acid on human stratum corneum: ultrastructural and functional evaluation of the epidermal barrier.
Arch Dermatol Res (1997) · Open-Label
Electron-microscopy study of human skin after 3 weeks of 4% glycolic acid twice daily
Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase
J Invest Dermatol (2018) · In Vitro
The discovery paper, and the reason this ingredient exists: most tyrosinase inhibitors were screened against MUSHROOM tyrosinase, which is why so many lack clinical effect.
Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial
J Eur Acad Dermatol Venereol (2021) · RCT · n=50
The comparison that matters: head to head against 4% hydroquinone, the prescription-strength benchmark.
Thiamidol in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase
J Dermatol (2021) · RCT · n=48
The study the abstract calls the FIRST 24-week randomized, double-blind, vehicle-controlled assessment of thiamidol in moderate-to-severe melasma, with a subsequent regression phase.
Thiamidol has a higher evidence score (6.5/10 vs 6/10) and wins in 2 of 3 categories.
For even skin tone, Thiamidol has a higher relevance score (88 vs 60).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.